Patents Assigned to ARC Medical Inc.
  • High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
    Patent number: 12186334
    Abstract: High-molecular-weight fucan compositions comprising a therapeutically effective, medically acceptable fucan in a composition comprising wherein the fucan, for example, has a molecular weight distribution in which more than 60% w/w of the composition has a molecular weight above 100 kDa.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: January 7, 2025
    Assignee: ARC Medical Inc.
    Inventors: Christopher Michael Kevin Springate, Ian Millet, Sailesh Haresh Daswani, Hesong Sun
  • LOW ENDOTOXIN FUCAN COMPOSITIONS, SYSTEMS AND METHODS
    Publication number: 20240398851
    Abstract: Fucan-low endotoxin compositions comprising a therapeutically effective, medically acceptable fucan in a composition comprising less than about 0.2. 0.18. 0.1. 0.01. 0.001. or 0.0005 endotoxin units (EU) per milligram of the fucan.
    Type: Application
    Filed: January 3, 2024
    Publication date: December 5, 2024
    Applicant: ARC Medical Inc.
    Inventors: Christopher Michael Kevin Springate, Ian Millet, Sailesh Haresh Daswani, Hesong Sun, Aileen Shao Ting Yang, Hoi Ting Wong
  • FUCAN AND MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO CAPSULAR CONTRACTURE AND TO INHIBITING FIBROUS GROWTH AROUND OR ON TRANSPLANTS
    Publication number: 20240350531
    Abstract: Compositions and methods comprising medically-acceptable fucans suitable for medical and surgical applications, including treatment of capsular contracture and other foreign body reaction (FBR) conditions, and medical and surgical applications related to transplants and transplant operations, such as GVHD and fibrous growth around or on implants or transplants after implantation/transplantation, and related diseases, infections, and traumas.
    Type: Application
    Filed: August 18, 2022
    Publication date: October 24, 2024
    Applicant: ARC Medical Inc.
    Inventors: Hesong Sun, Ian Millet, Christopher Michael Kevin Springate
  • Low endotoxin fucan compositions, systems, and methods
    Patent number: 11938145
    Abstract: Low endotoxin fucan compositions comprising a therapeutically effective, medically acceptable fucan in a composition comprising less than about 0.2, 0.18, 0.1, 0.01, 0.001, or 0.0005 endotoxin units (EU) per milligram of the fucan are disclosed. Methods and systems for removing or reducing the amount of endotoxins from a starting fucan composition are also disclosed.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: March 26, 2024
    Assignee: ARC Medical Inc.
    Inventors: Christopher Michael Kevin Springate, Ian Millet, Sailesh Haresh Daswani, Hesong Sun, Aileen Shao Ting Yang, Hoi Ting Wong
  • HIGH-MOLECULAR-WEIGHT FUCANS FOR TREATING FIBROUS ADHESIONS AND OTHER DISEASES AND CONDITIONS
    Publication number: 20230140869
    Abstract: High-molecular-weight fucan compositions comprising a therapeutically effective, medically acceptable fucan in a composition comprising wherein the fucan, for example, has a molecular weight distribution in which more than 60% w/w of the composition has a molecular weight above 100 kDa.
    Type: Application
    Filed: July 27, 2022
    Publication date: May 11, 2023
    Applicant: ARC Medical Inc.
    Inventors: Christopher Michael Kevin Springate, Ian Millet, Sailesh Haresh Daswani, Hesong Sun
  • Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions
    Patent number: 11642368
    Abstract: Compositions, methods, systems, etc., are provided for modified and/or purified fucans and corresponding fucan-containing compositions that inhibit fibrous adhesions among other advantages. The purified/modified fucans and fucan compositions have a reduced level of non-fucan components or impurities such as those found in a starting fucan composition. Such reduced undesirable components or impurities include, for example, undesired components bound to the fucan and compounds in the composition that are not a part of or bound to the fucan.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: May 9, 2023
    Assignee: ARC Medical Inc.
    Inventors: Christopher Michael Kevin Springate, Ian Millet, Sailesh Haresh Daswani, Hesong Sun, Aileen Shao Ting Yang, Hoi Ting Wong